The Low Density Lipoprotein Test Global Market Report 2023, provides comprehensive information on the low density lipoprotein test market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Low Density Lipoprotein Test Market’s Growth:
https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report
As per The Business Research Company’s Low Density Lipoprotein Test Global Market Report 2023, the global low-density lipoprotein test market size is expected to grow from $7.80 billion in 2022 to $8.13 billion in 2023 at a compound annual growth rate (CAGR) of 4.14%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The low-density lipoprotein test market size is expected to reach $9.47 billion in 2027 at a CAGR of 3.91%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9395&type=smp
Product innovations are a key trend gaining popularity in the low-density lipoprotein test markets. Major companies operating in the low-density lipoprotein test market are introducing innovative products to sustain their position in the market. For instance, in December 2021, Novartis AG, a Switzerland-based multinational pharmaceutical corporation, launched Leqvio (Inclisiran), a first-in-class siRNA (small interfering RNA therapy) to lower low-density lipoprotein cholesterol. This medication provides effective and sustained reductions in low-density lipoprotein cholesterol. Leqvio is the first and only small interfering RNA (siRNA) medication for lowering LDL-C (bad cholesterol) that has received FDA approval, requiring just two maintenance doses per year. For some patients with atherosclerotic cardiovascular disease (ASCVD) receiving maximally tolerated statin therapy, Leqvio offers an effective and long-lasting LDL-C decrease of up to 52% in comparison to placebo. Leqvio is a ground-breaking method to reduce LDL-C that also opens up new opportunities for how healthcare systems can affect cardiovascular disease.
The low density lipoprotein test market is segmented:
1) By Product Type: LDL-C, LDL-P, LDL-B, Other Products
2) By Component: Kits, Reagents, Devices, Other Components
3) By Disease Type: Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Other Disease Types
4) By Distribution Channel: Direct Tenders, Retail
5) By End User: Hospitals, Clinics, Ambulatory Care, Research Laboratory, Other End Users
North America was the largest region in the low density lipoprotein test market in 2022.
The table of contents in TBRC’s low density lipoprotein test market report includes:
- Executive Summary
- Low-Density Lipoprotein Test Market Characteristics
- Low-Density Lipoprotein Test Market Trends And Strategies
- Low-Density Lipoprotein Test Market – Macro Economic Scenario
- Low-Density Lipoprotein Test Market Size And Growth.
.
.
.
- Africa Low-Density Lipoprotein Test Market
- Low-Density Lipoprotein Test Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Low-Density Lipoprotein Test Market
- Low-Density Lipoprotein Test Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
